Loading...
Hepatitis B reactivation in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor
Hepatitis B virus (HBV) reactivation is a well-recognized complication in patients with chronic HBV infection receiving cytotoxic or immunosuppressive chemotherapy. Imatinib mesylate and nilotinib are selective Bcr/Abl tyrosine kinase inhibitors, which are now widely used in the treatment of patient...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Baishideng Publishing Group Co., Limited
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3587491/ https://ncbi.nlm.nih.gov/pubmed/23483799 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v19.i8.1318 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|